Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Color-Blind Racial Attitudes in Dental Hygiene Students: A pilot study.

Ludwig EA, Suedbeck JR, Tolle SL.

J Dent Hyg. 2019 Oct;93(5):15-22.

PMID:
31628172
2.

Population Pharmacokinetics and Exposure - Safety Analyses of Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma.

Wang X, Ludwig EA, Passarell J, Bello A, Roy A, Hruska MW.

J Clin Pharmacol. 2019 Mar;59(3):364-373. doi: 10.1002/jcph.1324. Epub 2018 Oct 19.

PMID:
30339279
3.

Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.

Sunkaraneni S, Ludwig EA, Passarell JA, Blum D, Grinnell T, Fiedler-Kelly J.

J Clin Pharmacol. 2018 Jul;58(7):927-938. doi: 10.1002/jcph.1086. Epub 2018 Mar 12.

PMID:
29528499
4.

The Effect of Magnification Loupes on Dental Hygienists' Posture while Exploring.

Ludwig EA, McCombs GB, Tolle SL, Russell DM.

J Dent Hyg. 2017 Aug;91(4):46-52.

PMID:
29118083
5.

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy.

Sunkaraneni S, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, Blum D.

Clin Pharmacol. 2017 Jun 27;9:65-72. doi: 10.2147/CPAA.S133815. eCollection 2017.

6.

Population pharmacokinetic meta-analysis of trabectedin (ET-743, Yondelis) in cancer patients.

Perez-Ruixo JJ, Zannikos P, Hirankarn S, Stuyckens K, Ludwig EA, Soto-Matos A, Lopez-Lazaro L, Owen JS.

Clin Pharmacokinet. 2007;46(10):867-84.

PMID:
17854236
7.

Population pharmacokinetics of tigecycline in healthy volunteers.

Van Wart SA, Cirincione BB, Ludwig EA, Meagher AK, Korth-Bradley JM, Owen JS.

J Clin Pharmacol. 2007 Jun;47(6):727-37.

PMID:
17519399
8.

Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder.

Vermeulen A, Piotrovsky V, Ludwig EA.

J Pharmacokinet Pharmacodyn. 2007 Apr;34(2):183-206. Epub 2006 Nov 29.

PMID:
17136449
9.

Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections.

Van Wart SA, Owen JS, Ludwig EA, Meagher AK, Korth-Bradley JM, Cirincione BB.

Antimicrob Agents Chemother. 2006 Nov;50(11):3701-7. Epub 2006 Aug 28.

10.

Challenges in the transition to model-based development.

Grasela TH, Fiedler-Kelly J, Walawander CA, Owen JS, Cirincione BB, Reitz KE, Ludwig EA, Passarell JA, Dement CW.

AAPS J. 2005 Oct 5;7(2):E488-95. Review.

11.

Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections.

Van Wart S, Phillips L, Ludwig EA, Russo R, Gajjar DA, Bello A, Ambrose PG, Costanzo C, Grasela TH, Echols R, Grasela DM.

Antimicrob Agents Chemother. 2004 Dec;48(12):4766-77.

12.

A population pharmacokinetic-pharmacodynamic analysis and model validation of azimilide.

Phillips L, Grasela TH, Agnew JR, Ludwig EA, Thompson GA.

Clin Pharmacol Ther. 2001 Oct;70(4):370-83.

PMID:
11673753
13.

Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.

Slayter KL, Ludwig EA, Lew KH, Middleton E Jr, Ferry JJ, Jusko WJ.

Clin Pharmacol Ther. 1996 Mar;59(3):312-21.

PMID:
8653994
14.

Methylprednisolone pharmacokinetics and pharmacodynamics in chronic renal failure.

Jusko WJ, Milad MA, Ludwig EA, Lew KH, Kohli RK.

Clin Nephrol. 1995 Jan;43 Suppl 1:S16-9.

PMID:
7781199
15.

Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.

Milad MA, Ludwig EA, Anné S, Middleton E Jr, Jusko WJ.

J Pharmacokinet Biopharm. 1994 Dec;22(6):469-80.

PMID:
7473077
16.

The Pharmacokinetics and Pharmacodynamics of Methylprednisolone in Chronic Renal Failure.

Milad MA, Ludwig EA, Lew KH, Kohli RK, Jusko WJ.

Am J Ther. 1994 Jun;1(1):49-57.

PMID:
11835067
17.

Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.

Lew KH, Ludwig EA, Milad MA, Donovan K, Middleton E Jr, Ferry JJ, Jusko WJ.

Clin Pharmacol Ther. 1993 Oct;54(4):402-14.

18.

Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.

Ludwig EA, Kong AN, Camara DS, Jusko WJ.

J Clin Pharmacol. 1993 Sep;33(9):805-10.

PMID:
8227476
19.

Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man.

Wald JA, Law RM, Ludwig EA, Sloan RR, Middleton E Jr, Jusko WJ.

J Pharmacokinet Biopharm. 1992 Dec;20(6):567-89.

PMID:
1302763
20.

Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes.

Fisher LE, Ludwig EA, Jusko WJ.

J Pharmacokinet Biopharm. 1992 Aug;20(4):319-31.

21.

Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

Fisher LE, Ludwig EA, Wald JA, Sloan RR, Middleton E Jr, Jusko WJ.

Clin Pharmacol Ther. 1992 Jun;51(6):677-88.

22.

Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone.

Yamashita SK, Ludwig EA, Middleton E Jr, Jusko WJ.

Clin Pharmacol Ther. 1991 May;49(5):558-70.

PMID:
1827622
23.

Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.

Dunn TE, Ludwig EA, Slaughter RL, Camara DS, Jusko WJ.

Clin Pharmacol Ther. 1991 May;49(5):536-49.

PMID:
1827621
24.

Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man.

Reiss WG, Slaughter RL, Ludwig EA, Middleton E Jr, Jusko WJ.

J Allergy Clin Immunol. 1990 Jun;85(6):1058-66.

PMID:
2191992
25.

Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.

Kong AN, Ludwig EA, Slaughter RL, DiStefano PM, DeMasi J, Middleton E Jr, Jusko WJ.

Clin Pharmacol Ther. 1989 Dec;46(6):616-28.

26.

Steroid-specific effects of ketoconazole on corticosteroid disposition: unaltered prednisolone elimination.

Ludwig EA, Slaughter RL, Savliwala M, Brass C, Jusko WJ.

DICP. 1989 Nov;23(11):858-61.

PMID:
2596127
27.

Lack of effect of atenolol on the pharmacokinetics of theophylline.

Cerasa LA, Bertino JS Jr, Ludwig EA, Savliwala M, Middleton E Jr, Slaughter RL.

Br J Clin Pharmacol. 1988 Dec;26(6):800-2.

Supplemental Content

Loading ...
Support Center